Regencell Bioscience Holdings Limited

NASDAQ:RGC

15.29 (USD) • At close July 16, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 00000000-2,341.8000-2,341.80000000
Kosten van de omzet 00000.770000.604000877.70000000
Brutowinst 0000-0.77000-2,342.404000-3,219.50000000
Brutowinstmarge 0000000010001.3750000000
Onderzoek- en ontwikkelingskosten 0.5810000.23101.350.0011.3970.0011.1150.00100000000
Algemene en administratieve kosten 0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00100000000
Verkoop- en marketingkosten 00000000000000000000
Verkoop-, algemene en administratieve kosten 1.8430.0010.0010.0011.8430.0012.0790.0011.9580.0012.5440.00100000000
Overige kosten 0-00000000000-285.70000000
Bedrijfskosten 2.4250.0010.0010.0012.0740.0013.430.0023.3540.0023.6590.0020.0010.001000000
Bedrijfsresultaat -2.425-0.001-0.001-0.001-2.844-0.001-3.43-0.002-3.959-0.002-3.659-0.002-0.001-0.001-0-0-0-0-0-0
Bedrijfsresultaat ratio 000000000.00200000000000
Totaal overige inkomsten en kosten netto 0.2480-1.03-1.0920.097-1.3720.114-1.656-1.956-1.9660-1.8280.506-0000000
Inkomen voor belasting -2.177-0.001-0.001-0.001-2.747-0.001-3.315-0.002-3.936-0.002-3.659-0.002-0.001-0.001-0-0-0-0-0-0
Inkomen voor belasting ratio 000000000.00200000000000
Belastingkosten 00-0.119-00-00-0-0-0-0-0-70.90000000
Nettowinst -2.235-0.001-0.001-0.001-2.644-0.001-3.227-0.002-3.936-0.002-3.659-0.002-0.001-0.001-0-0-0-0-0-0
Nettowinstmarge 000000000.00200000000000
WPA (Winst Per Aandeel) -0.004-0-0-0-0.005-0-0.007-0-0.008-0-0.007-0-0-0-0-0-0.001-0.001-0-0
Verwaterde WPA -0.004-0-0-0-0.005-0-0.007-0-0.008-0-0.007-0-0-0-0-0-0.001-0.001-0-0
EBITDA -2.177-0.001-2.186-1.083-1.976-1.385-3.43-1.677-3.331-1.973-3.659-1.823-0.5-0.5-0.178-0.178-0.255-0.257-0.149-0.149
EBITDA ratio 000000000.00100000000000